Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 2/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.36 |
| ▸ | CTSG | P08311 | 2/20 | 0.36 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.36 |
| ▸ | CMA1 | P23946 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.35 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALPI | P09923 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALPG | P10696 | 1/20 | 0.35 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | GALK1 | P51570 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5855399 | 1.00 | TDP1 (0.39) | TDP1MMP12PRSS1CTSGCTRB1 | |
| SCHEMBL16414459 | 0.90 | MMP12 (0.38) | TDP1MMP12PRSS1CTSGCTRB1 | |
| SCHEMBL16414506 | 0.90 | MMP12 (0.38) | TDP1MMP12PRSS1CTSGCTRB1 | |
| SCHEMBL16414460 | 0.90 | MMP12 (0.38) | TDP1MMP12PRSS1CTSGCTRB1 | |
| SCHEMBL20436626 | 0.87 | TRPA1 (0.38) | TDP1MAPTTSHR | |
| SCHEMBL15581687 | 0.87 | PRSS1 (0.38) | MMP12PRSS1CTSGCTRB1CMA1 | |
| SCHEMBL10086857 | 0.85 | ALDH1A1 (0.40) | MMP12PRSS1CTSGCTRB1CMA1 | |
| SCHEMBL2491826 | 0.85 | TDP1 (0.39) | TDP1MMP12PRSS1CTSGCTRB1 | |
| SCHEMBL17460916 | 0.85 | PRSS1 (0.36) | MMP12PRSS1CTSGCTRB1CMA1 | |
| SCHEMBL6139453 | 0.85 | PRSS1 (0.36) | MMP12PRSS1CTSGCTRB1CMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1385819-B1 | PROCESS FOR PREPARING PROSTAGLANDIN DERIVATIVES AND STEREOSPECIFIC STARTING MATERIAL THEREOF | YONSUNG FINE CHEMICAL CO LTD (KR) | 2015-12-23 | — | — | EP | disclosed |
| US-6989458-B2 | Process for preparing prostaglandin derivatives and stereospecific starting material thereof | YONSUNG FINE CHEMICAL CO. (KR) | 2006-01-24 | — | — | US | disclosed |
| US-20050192451-A1 | Process for preparing prostaglandin derivatives and stereospecific starting material thereof | HAM WON-HUN (KR) | 2005-09-01 | — | — | US | disclosed |
| US-6852880-B2 | Process for preparing prostalglandin derivatives and stereospecific starting material thereof | YONSUNG FINE CHEMICAL CO. (KR) | 2005-02-08 | — | — | US | disclosed |
| EP-1385819-A4 | PROCESS FOR PREPARING PROSTAGLANDIN DERIVATIVES AND STEREOSPECIFIC STARTING MATERIAL THEREOF | YONSUNG FINE CHEMICAL CO LTD (KR) | 2005-01-26 | — | — | EP | disclosed |
| US-20040116693-A1 | Process for preparing prostalglandin derivatives and stereospecific starting material thereof | YONSUNG FINE CHEMICAL CO. (KR) | 2004-06-17 | — | — | US | disclosed |
| EP-1385819-A1 | PROCESS FOR PREPARING PROSTAGLANDIN DERIVATIVES AND STEREOSPECIFIC STARTING MATERIAL THEREOF | Yonsung Fine Chemical Co. Ltd (KR) | 2004-02-04 | — | — | EP | disclosed |
| WO-2002090324-A1 | PROCESS FOR PREPARING PROSTAGLANDIN DERIVATIVES AND STEREOSPECIFIC STARTING MATERIAL THEREOF | YONSUNG FINE CHEMICAL CO. (KR) | 2002-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192451-A1 | Process for preparing prostaglandin derivatives and stereospecific starting material thereof | PTGIS, HPGDS, PTGES | TDP1 4791/4885MMP12 2915/4885PRSS1 384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.